Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial-Reference-Cited by-同舟云学术

Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial

Published:2000-03 Issue:9206 Volume:355 Page:792-797
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Faris Patricia L,Kim Suck Won,Meller William H,Goodale Robert L,Oakman Scott A,Hofbauer Randall D,Marshall Anne M,Daughters Randall S,Banerjee-Stevens Devjani,Eckert Elke D,Hartman Boyd K

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Epidemiology of the eating disorders;Hsu;Psychiatr Clin North Am,1996

2. Diagnostic and statistical manual of mental disorders,1994

3. Outcome in bulimia nervosa;Keel;Am J Psychiatry,1997

4. Nociceptive, but not tactile, thresholds are elevated in bulimia nervosa;Faris;Biol Psychiatry,1992

5. Behavioral assessment of satiety in bulimia nervosa;Hadigan;Appetite,1992

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials;Journal of Affective Disorders;2023-10

2. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders;The World Journal of Biological Psychiatry;2023-04-24

3. An overview of the treatment of eating disorders in adults and adolescents: pharmacology and psychotherapy;Postępy Psychiatrii i Neurologii;2023

4. A specific association between laxative misuse and suicidal behaviours in patients with anorexia nervosa and bulimia nervosa;Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity;2021-04-01

5. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences;Pharmacology & Therapeutics;2021-01